Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 A-Mark Precious Metals, Inc. AMRK Jun 26, 2017 15.60 +1.17   
 A. Schulman SHLM Jun 26, 2017 28.55 -0.52   
 Aaon Inc AAON Jun 26, 2017 36.05 -0.41   
 Abaxis Inc ABAX Jun 26, 2017 52.94 +0.76   
 Abeona Therapeutics Inc. ABEOW Jun 26, 2017 3.00 0.00   
 Abeona Therapeutics Inc. ABEO Jun 26, 2017 5.95 -0.83   
 Ability Inc. ABIL Jun 26, 2017 1.40 +11.11   
 Abiomed ABMD Jun 26, 2017 142.78 -1.18   
 Abraxas Petroleum Corp AXAS Jun 26, 2017 1.58 -0.63   
 AC Immune SA ACIU Jun 26, 2017 9.24 -1.60   
 Acacia Communications, Inc. ACIA Jun 26, 2017 43.33 -2.89   
 Acacia Research Corp ACTG Jun 26, 2017 4.15 +1.22   
 Acadia Healthcare Company Inc ACHC Jun 26, 2017 47.84 -0.40   
 Acadia Pharmaceuticals Inc ACAD Jun 26, 2017 29.01 -0.79   
 Acasti Pharma Inc ACST Jun 26, 2017 1.30 +3.17   
 Accelerate Diagnostics Inc AXDX Jun 26, 2017 28.50 -5.79   
 Acceleron Pharma Inc XLRN Jun 26, 2017 31.01 -9.06   
 Access National Corp ANCX Jun 26, 2017 25.90 +0.78   
 Accuray Incorporated ARAY Jun 26, 2017 4.75 +2.70   
 Acelrx Pharmaceuticals ACRX Jun 26, 2017 2.25 +4.65   
 Aceto Corp ACET Jun 26, 2017 15.86 +2.99   
 Achaogen, Inc. AKAO Jun 26, 2017 22.55 +0.89   
 Achillion Pharmaceuticals ACHN Jun 26, 2017 4.40 +0.46   
 Aci Worldwide ACIW Jun 26, 2017 22.91 -2.55   
 Aclaris Therapeutics, Inc. ACRS Jun 26, 2017 26.98 -0.74   
 Acnb Corp ACNB Jun 26, 2017 29.85 -0.50   
 Acorda Therapeutics ACOR Jun 26, 2017 19.20 -1.29   
 Acorn Energy ACFN Jun 26, 2017 0.24 -2.12   
 Active Alts Contrarian ETF SQZZ Jun 26, 2017 24.59 0.00   
 Activision Blizzard Inc ATVI Jun 26, 2017 60.22 -0.36   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK